Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Folic acid receptor-targeted solid lipid nanoparticles to enhance cytotoxicity of letrozole through induction of caspase-3 dependent-apoptosis for breast cancer treatment
Atefeh Yassemi, Soheila Kashanian, Hossein Zhaleh
Pharmaceutical Development and Technology (2020) Vol. 25, Iss. 4, pp. 397-407
Closed Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

Preparation of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Drug Delivery and the Effects of Preparation Parameters of Solvent Injection Method
Van‐An Duong, Thi‐Thao‐Linh Nguyen, Han‐Joo Maeng
Molecules (2020) Vol. 25, Iss. 20, pp. 4781-4781
Open Access | Times Cited: 208
Nanoparticles in Drug Delivery: From History to Therapeutic Applications
Obaid Afzal, Abdulmalik Saleh Alfawaz Altamimi, Muhammad Shahid Nadeem, et al.
Nanomaterials (2022) Vol. 12, Iss. 24, pp. 4494-4494
Open Access | Times Cited: 203
Nanomedicine-Based Delivery Strategies for Breast Cancer Treatment and Management
Priti Tagde, Agnieszka Najda, Kalpana Nagpal, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2856-2856
Open Access | Times Cited: 93
RETRACTED: Optimized Icariin Phytosomes Exhibit Enhanced Cytotoxicity and Apoptosis-Inducing Activities in Ovarian Cancer Cells
Nabil A. Alhakamy, Usama A. Fahmy, Shaimaa M. Badr-Eldin, et al.
Pharmaceutics (2020) Vol. 12, Iss. 4, pp. 346-346
Open Access | Times Cited: 94
A review of FDA approved drugs and their formulations for the treatment of breast cancer
Mohini Chaurasia, Romi Singh, Srija Sur, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 22
Folic Acid-Decorated Nanocrystals as Highly Loaded Trojan Horses to Target Cancer Cells
Marta G. Fuster, Jiawen Wang, Octavio E. Fandiño, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 6, pp. 2781-2794
Open Access | Times Cited: 8
Surface receptor‐mediated targeted drug delivery systems for enhanced cancer treatment: A state‐of‐the‐art review
Selvaraj Kunjiappan, Parasuraman Pavadai, Vellaichamy Sivakumar, et al.
Drug Development Research (2020) Vol. 82, Iss. 3, pp. 309-340
Closed Access | Times Cited: 61
Super Magnetic Niosomal Nanocarrier as a New Approach for Treatment of Breast Cancer: A Case Study on SK-BR-3 and MDA-MB-231 Cell Lines
Elham Jamshidifar, Faten Eshrati Yeganeh, Mona Shayan, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 7948-7948
Open Access | Times Cited: 49
Folate functionalized chitosan nanoparticles as targeted delivery systems for improved anticancer efficiency of cytarabine in MCF-7 human breast cancer cell lines
Deepa Geethakumari, B.S. Anoop, Krishnapriya Raji Sathyan, et al.
International Journal of Biological Macromolecules (2021) Vol. 199, pp. 150-161
Closed Access | Times Cited: 44
Self-assembled hydrogel nanocube for stimuli responsive drug delivery and tumor ablation by phototherapy against breast cancer
Mukherjee Arjama, Sivaraj Mehnath, Murugaraj Jeyaraj
International Journal of Biological Macromolecules (2022) Vol. 213, pp. 435-446
Closed Access | Times Cited: 29
Evaluation of anti-cancer and anti-metastatic effects of folate-PEGylated niosomes for co-delivery of letrozole and ascorbic acid on breast cancer cells
Mahsa Bourbour, Nazanin Khayam, Hassan Noorbazargan, et al.
Molecular Systems Design & Engineering (2022) Vol. 7, Iss. 9, pp. 1102-1118
Closed Access | Times Cited: 28
Nano-drug Delivery System: a Promising Approach Against Breast Cancer
Jonaid Ahmad Malik, Jeba Ajgar Ansari, Sakeel Ahmed, et al.
Therapeutic Delivery (2023) Vol. 14, Iss. 5, pp. 357-381
Open Access | Times Cited: 21
Nanomedicine in therapeutic warfront against estrogen receptor–positive breast cancer
Mayur Aalhate, Srushti Mahajan, Hoshiyar Singh, et al.
Drug Delivery and Translational Research (2023) Vol. 13, Iss. 6, pp. 1621-1653
Closed Access | Times Cited: 18
Overview of Solid Lipid Nanoparticles in Breast Cancer Therapy
Kyumin Mo, Ayoung Kim, Soohyun Choe, et al.
Pharmaceutics (2023) Vol. 15, Iss. 8, pp. 2065-2065
Open Access | Times Cited: 17
Surface-modified lipid-based nanocarriers as a pivotal delivery approach for cancer therapy: application and recent advances in targeted cancer treatment‏
Doaa M. Anwar, Heidy Y. Hedeya, Sama H. Ghozlan, et al.
Beni-Suef University Journal of Basic and Applied Sciences (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Scorpion Venom-Functionalized Quercetin Phytosomes for Breast Cancer Management: In Vitro Response Surface Optimization and Anticancer Activity against MCF-7 Cells
Nabil A. Alhakamy, Usama A. Fahmy, Shaimaa M. Badr-Eldin, et al.
Polymers (2021) Vol. 14, Iss. 1, pp. 93-93
Open Access | Times Cited: 34
Development and Characterization of Folic Acid-Conjugated Amodiaquine-Loaded Nanoparticles–Efficacy in Cancer Treatment
Vineela Parvathaneni, Snehal K. Shukla, Vivek Gupta
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 1001-1001
Open Access | Times Cited: 15
Nanotechnology-based drug delivery for breast cancer treatment: Current applications and future directions
Md Abdus Samad, Iftikhar Ahmad, Torki A. Zughaibi, et al.
European Journal of Medicinal Chemistry Reports (2025), pp. 100268-100268
Open Access
Morin hydrate loaded solid lipid nanoparticles: Characterization, stability, anticancer activity, and bioavailability
Swathi Karamchedu, Lakshmi Tunki, Hitesh Kulhari, et al.
Chemistry and Physics of Lipids (2020) Vol. 233, pp. 104988-104988
Closed Access | Times Cited: 38
Encapsulation of cucurbitacin B into lipid polymer hybrid nanocarriers induced apoptosis of MDAMB231 cells through PARP cleavage
Filiz Bakar‐Ates, Erva Özkan, Ceyda Tuba Şengel-Türk
International Journal of Pharmaceutics (2020) Vol. 586, pp. 119565-119565
Closed Access | Times Cited: 37
Combination Therapy and Nanoparticulate Systems: Smart Approaches for the Effective Treatment of Breast Cancer
Shivaprasad Gadag, Shristi Sinha, Yogendra Nayak, et al.
Pharmaceutics (2020) Vol. 12, Iss. 6, pp. 524-524
Open Access | Times Cited: 35
Receptor-Mediated Targeted Delivery of Surface-ModifiedNanomedicine in Breast Cancer: Recent Update and Challenges
Md. Rizwanullah, Mohammad Zaki Ahmad, Mohammed M. Ghoneim, et al.
Pharmaceutics (2021) Vol. 13, Iss. 12, pp. 2039-2039
Open Access | Times Cited: 30
Evaluation of folic acid functionalized BSA-CaFe2O4 nanohybrid carrier for the controlled delivery of natural cytotoxic drugs hesperidin and eugenol
Palanisamy Uma Maheswari, Rhea Muthappa, Bindhya K. Purushothaman, et al.
Journal of Drug Delivery Science and Technology (2020) Vol. 61, pp. 102105-102105
Closed Access | Times Cited: 31
N-acetyl-d-glucosamine decorated nano-lipid-based carriers as theranostics module for targeted anti-cancer drug delivery
Rahul Kumar, Divya divya, Supratim Mahapatra, et al.
Materials Chemistry and Physics (2022) Vol. 282, pp. 125956-125956
Closed Access | Times Cited: 18
Potentialities of fluorescent carbon nanomaterials as sensor for food analysis
Piyali Sabui, Sadhucharan Mallick, Kshitij RB Singh, et al.
Luminescence (2022) Vol. 38, Iss. 7, pp. 1047-1063
Closed Access | Times Cited: 18
Page 1 - Next Page

Scroll to top